CSIMarket


Alkermes Plc   (NASDAQ: ALKS)
Other Ticker:  
 

Alkermes Plc

ALKS's Fundamental analysis








Alkermes Plc 's sales fell by -0.73 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 2274

Major Pharmaceutical Preparations industry recorded growth of revenues by 9.75 %

Alkermes Plc 's net income grew by 93.44 % in III. Quarter 2024 year on year, above company average,

More on ALKS's Growth


Alkermes Plc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Alkermes Plc PEG ratio is at 0.3 Alkermes Plc realized cash reduction of $ -1.51 per share in trailing twelve-month period.
Company
16.61
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 3.55.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.41.


More on ALKS's Valuation
 
 Total Debt (Millions $) 289
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 716,724
 Net Income/Employee (TTM) $ 158,736
 Receivable Turnover (TTM) 4.36
 Tangible Book Value (Per Share $) 7.23

Alkermes Plc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Alkermes Plc PEG ratio is at 0.3 Alkermes Plc realized cash outflow of $ -1.51per share in trailing twelve-month period.
Company
16.61
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 3.55.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.41.

Alkermes Plc Price to Book Ratio is at 4.13 lower than Industry Avg. of 82.25. and higher than S&P 500 Avg. of 0.02

More on ALKS's Valuation

  Market Capitalization (Millions $) 5,338
  Shares Outstanding (Millions) 167
  Employees 2,100
  Revenues (TTM) (Millions $) 1,505
  Net Income (TTM) (Millions $) 333
  Cash Flow (TTM) (Millions $) -251
  Capital Exp. (TTM) (Millions $) -41
  Total Debt (Millions $) 289
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 716,724
  Net Income/Employee(TTM) $ 158,736
  Receivable Turnover Ratio (TTM) 4.36
  Tangible Book Value (Per Share $) 7.23

  Market Capitalization (Millions $) 5,338
  Shares Outstanding (Millions) 167
  Employees 2,100
  Revenues (TTM) (Millions $) 1,505
  Net Income (TTM) (Millions $) 333
  Cash Flow (TTM) (Millions $) -251
  Capital Exp. (TTM) (Millions $) -41


    ALKS's Profitability Comparisons
Alkermes Plc achieved increase in profitability, decrease in demand. Operating Margin grew in III. Quarter 2024 to 27.7 % from 27.53 % in II. Quarter.

Alkermes Plc net profit margin of 24.43 % is currently ranking no. 23 in Major Pharmaceutical Preparations industry, ranking no. 42 in Healthcare sector and number 547 in S&P 500.


Profitability by Segment
Total 24.43 %



  Ratio
   Capital Ratio (MRQ) 3.45
  Total Debt to Equity (MRQ) 0.22
  Tangible Leverage Ratio (MRQ) 0.66
  Asset Turnover Ratio (TTM) 0.73
  Inventory Turnover Ratio (TTM) 1.31



Alkermes Plc achieved increase in profitability, decrease in demand. Operating Margin grew in III. Quarter 2024 to 27.7 % from 27.53 % in II. Quarter.

Alkermes Plc net profit margin of 24.43 % is currently ranking no. 23 in Major Pharmaceutical Preparations industry, ranking no. 42 in Healthcare sector and number 547 in S&P 500.

More on ALKS's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com